openPR Logo
Press release

Vision Care Market to Reach US$ 93.57 Bn. by 2029, Growing at a 4.5% CAGR

Vision Care Market:

Vision Care Market:

Age-Related Macular Degeneration (AMD) Market: Growth, Dynamics, and Future Outlook

The Age-Related Macular Degeneration (AMD) Market size was valued at USD 9.45 Billion in 2024, and the total AMD Market revenue is expected to grow at a CAGR of 7.2% from 2025 to 2032, reaching nearly USD 16.50 Billion.

Market Overview

The Age-Related Macular Degeneration (AMD) Market represents a critical segment of the global ophthalmology and vision care industry. AMD is one of the leading causes of vision loss among the elderly population, particularly in developed and aging economies.

Market growth is primarily driven by the rising geriatric population, increasing prevalence of lifestyle-related eye disorders, and growing awareness about early diagnosis and treatment options. Advancements in biologics, anti-VEGF therapies, and sustained-release drug delivery systems are significantly improving treatment outcomes.

Additionally, improved access to eye care services, favorable reimbursement policies in developed regions, and increasing R&D investments are accelerating market expansion.

Access Premium Market Insights - Limited-Time 30% Off : https://www.maximizemarketresearch.com/market-report/global-age-related-macular-degeneration-amd-market/36109/

Market Key

Rising prevalence of age-related eye disorders worldwide
Strong demand for anti-VEGF therapies
Advancements in biologics and gene-based treatments
Growing geriatric population globally
Increasing awareness and early diagnosis initiatives

Market Size & Forecast

2024: US $ 10.25 Bn.
2032: US $ 11.25 Bn.
CAGR (2025-2032): 12.7%

Age-Related Macular Degeneration (AMD) Market Segmentation

by Drug Type

Lucentis
Eylea
Beovu
Others

by Disease Type

Dry AMD
Wet AMD

by Age Group

Less Than 60
Between 60 to 80
More Than 80

by Gender

Male
Female

Key Growth Drivers

Growing Aging Population
Rapidly increasing elderly populations across the globe are significantly raising AMD incidence rates.

Technological Advancements
Innovations in biologics, gene therapy, and sustained drug delivery systems are transforming AMD treatment.

Rising Awareness and Screening Programs
Government and private initiatives promoting early diagnosis are improving treatment adoption.

Improved Healthcare Infrastructure
Expansion of ophthalmology clinics and access to advanced therapies is boosting market demand.

Pain Points & Challenges

High cost of advanced AMD therapies
Limited treatment options for dry AMD
Risks associated with repeated intravitreal injections
Uneven access to advanced eye care in developing regions

Emerging Opportunities

Development of long-acting and sustained-release therapies
Growth in gene and cell-based treatment approaches
Expansion into emerging markets with aging populations
Increased investment in dry AMD treatment research

Recent Developments & Trends

Launch of next-generation anti-VEGF therapies
Increased clinical trials focused on dry AMD treatments
Strategic collaborations between pharma companies and research institutes
Rising adoption of combination therapies for improved outcomes

Interested in detailed insights? Inquire for a sample report : https://www.maximizemarketresearch.com/request-sample/36109/

Frequently Asked Questions

1] What is the growth rate of the Age-Related Macular Degeneration (AMD) Market?
Ans. The AMD Market is expected to grow at a CAGR of 7.2% during the forecast period.

2] What is the expected market size of the AMD Market by 2032?
Ans. The market is expected to reach nearly USD 16.50 Billion by 2032.

3] Which segment dominates the AMD Market?
Ans. The anti-VEGF drug segment dominates due to its high efficacy in treating wet AMD.

4] What factors are driving the AMD Market growth?
Ans. Growth is driven by aging populations, technological advancements, rising awareness, and improved access to eye care.

5] Who are the key players in the AMD Market?
Ans. Key players include Roche, Novartis, Regeneron Pharmaceuticals, Bayer, and Allergan (AbbVie).

Related Reports

Ophthalmic Drugs Market : https://www.maximizemarketresearch.com/market-report/global-ophthalmology-drugs-and-devices-market/113937/

Retinal Disorders Treatment Market : https://www.maximizemarketresearch.com/market-report/retinal-vasculitis-treatment-market/121894/

Top Performing Market Reports

Biologics Market : https://www.maximizemarketresearch.com/market-report/biologics-market/37255/

Global Vision Care Market : https://www.maximizemarketresearch.com/market-report/global-vision-care-market/72274/

Contact Us

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Navale IT Park Phase 3,
Pune Bangalore Highway, Narhe
Pune, Maharashtra 411041, India.
📞 +91 9607365656
✉️ sales@maximizemarketresearch.com

About Us

Maximize Market Research is a leading market research and business consulting firm serving clients globally. We provide in-depth insights and actionable intelligence across industries including healthcare, pharmaceuticals, IT, automotive, chemicals, food & beverages, and more.

Analytics Partner :

https://www.mmrstatistics.com/

MMRStatistics is an advanced market intelligence platform delivering data-driven insights, forecasts, and industry trends across global markets. Powered by robust research methodologies, it helps businesses decode complex industries with clarity and confidence.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vision Care Market to Reach US$ 93.57 Bn. by 2029, Growing at a 4.5% CAGR here

News-ID: 4345516 • Views: …

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Biomethane Market Size, Share, and Global Growth Forecast (2026-2032)
Biomethane Market Size, Share, and Global Growth Forecast (2026-2032)
Biomethane Market size was valued at USD 5.93 Billion in 2025 and the total Biomethane revenue is expected to grow at a CAGR of 6.08% from 2026 to 2032, reaching nearly USD 8.96 Billion. Biomethane Market Overview: The biomethane market has emerged as an essential pillar of the world's transition toward a circular economy and net-zero energy networks. Valued at a substantial USD 5.93 Billion in 2025, the total global revenue of…
Water Treatment Chemicals Market Size, Share, and Global Growth Forecast (2026-2032)
Water Treatment Chemicals Market Size, Share, and Global Growth Forecast (2026-2 …
Water Treatment Chemicals Market size was valued at USD 39.98 Bn. in 2025, and the total Water Treatment Chemicals Market revenue is expected to grow by 4.83% from 2026 to 2032, reaching nearly USD 55.62 Bn. Water Treatment Chemicals Market Overview: The global water treatment chemicals market represents a critical and foundational backbone within public municipal infrastructure, modern industrial operations, and environmental conservation frameworks. Valued at a substantial USD 39.98 Billion in…
Paints and Coatings Market to Hit USD 294.82 Billion by 2032 at 4.16% CAGR
Paints and Coatings Market to Hit USD 294.82 Billion by 2032 at 4.16% CAGR
Paints and Coatings Market size was valued at USD 221.64 Billion in 2025 and the total Paints and Coatings revenue is expected to grow at a CAGR of 4.16% from 2025 to 2032, reaching nearly USD 294.82 Billion by 2032. Paints and Coatings Market Overview: The paints and coatings market represents a foundational and highly diverse sector operating at the intersection of heavy manufacturing, chemical engineering, and urban real estate. Valued at…
Mesh App and Service Architecture Market Size, Share, and Global Forecast (2025-2032)
Mesh App and Service Architecture Market Size, Share, and Global Forecast (2025- …
Mesh App and Service Architecture Market size was valued at USD 3.46 Billion in 2025 and the total revenue is expected to grow at a CAGR of 5% from 2025 to 2032, reaching nearly USD 4.87 Billion. Mesh App and Service Architecture Market Overview: The mesh app and service architecture market represents a highly specialized foundational vertical within the modern enterprise software and cloud native computing landscapes. Valued at a substantial USD…

All 5 Releases


More Releases for AMD

Emerging Age-related Macular Degeneration (AMD) Therapies: Key Pipeline Drugs an …
DelveInsight's Age-related Macular Degeneration (AMD) Pipeline Insight 2026 report provides comprehensive global coverage of available, marketed, and pipeline AMD therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Age-related Macular Degeneration (AMD) pipeline domain. Key takeaways from the AMD Clinical Trial Landscape Report • DelveInsight's AMD pipeline report depicts a robust space with 20+ active players working to develop…
Onlive Server Brings AI-Powered AMD Dedicated Servers
We are all aware of how useful, and sometimes even crucial, proper hosting services can be for a business. That is why Onlive Server is providing this new option with the newly recommended AI-powered AMD Dedicated Server Hosting[https://onliveserver.com/amd-dedicated-server-hosting/]. Furthermore, these servers are powered by AMD technology and do superbly in servicing the tremendous demand of agile business workloads with modern AI computations, big data, and other emerging technologies. AI-powered solutions are…
Age-related Macular Degeneration AMD Drugs Market Demand Driven by Rising Preval …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Age-related Macular Degeneration (AMD) Drugs Market Size, Share & Trends Analysis Report By Products (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre, Other Products), Molecules (Ranibizumab, Aflibercept, Faricimab, Pegcetoplan, Other Molecules), Type of AMD (Wet AMD, Dry AMD), Approval type (Biologic, Biosimilar) End User (Hospitals, Specialty Centers, Long-Term Care Facilities)- Market Outlook And Industry Analysis 2031" The…
06-13-2024 | Health & Medicine
Fact.MR
Age-Related Macular Degeneration Market To Expand, Fuelled By Innovations In Dry …
The Age-related Macular Degeneration Market (AMD) is poised for significant growth over the coming years, with projections indicating a compound annual growth rate (CAGR) of 6.2%, leading to an estimated market value of $20 billion by the end of the forecast period. This robust expansion is driven by several critical factors, including the rising prevalence of eye diseases, advancements in medical technology, and an aging population that is increasingly susceptible…
AMD Workstations Market | BIZON, BOXX Technologies, Broadberry, Dell
The global amd workstations market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the amd workstations market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving the growth of the…
Age-Related Macular Degeneration (AMD) Market Report 2018: Segmentation by Type …
Global Age-Related Macular Degeneration (AMD) market research report provides company profile for F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.…